1. Home
  2. MREO vs NL Comparison

MREO vs NL Comparison

Compare MREO & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • NL
  • Stock Information
  • Founded
  • MREO 2015
  • NL 1891
  • Country
  • MREO United Kingdom
  • NL United States
  • Employees
  • MREO N/A
  • NL N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • NL Major Chemicals
  • Sector
  • MREO Health Care
  • NL Industrials
  • Exchange
  • MREO Nasdaq
  • NL Nasdaq
  • Market Cap
  • MREO 424.5M
  • NL 362.9M
  • IPO Year
  • MREO N/A
  • NL N/A
  • Fundamental
  • Price
  • MREO $2.65
  • NL $7.12
  • Analyst Decision
  • MREO Strong Buy
  • NL Sell
  • Analyst Count
  • MREO 7
  • NL 1
  • Target Price
  • MREO $7.71
  • NL $6.00
  • AVG Volume (30 Days)
  • MREO 977.7K
  • NL 29.7K
  • Earning Date
  • MREO 05-13-2025
  • NL 05-07-2025
  • Dividend Yield
  • MREO N/A
  • NL 5.04%
  • EPS Growth
  • MREO N/A
  • NL 441.25
  • EPS
  • MREO N/A
  • NL 1.25
  • Revenue
  • MREO N/A
  • NL $148,242,000.00
  • Revenue This Year
  • MREO N/A
  • NL $15.75
  • Revenue Next Year
  • MREO $54.07
  • NL $2.44
  • P/E Ratio
  • MREO N/A
  • NL $5.74
  • Revenue Growth
  • MREO N/A
  • NL N/A
  • 52 Week Low
  • MREO $1.58
  • NL $5.21
  • 52 Week High
  • MREO $5.02
  • NL $9.42
  • Technical
  • Relative Strength Index (RSI)
  • MREO 63.52
  • NL 35.81
  • Support Level
  • MREO $2.11
  • NL $7.10
  • Resistance Level
  • MREO $2.27
  • NL $7.59
  • Average True Range (ATR)
  • MREO 0.14
  • NL 0.40
  • MACD
  • MREO 0.03
  • NL -0.10
  • Stochastic Oscillator
  • MREO 94.74
  • NL 1.48

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About NL NL Industries Inc.

NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

Share on Social Networks: